(c) 2023 PillSync.com

Ondansetron 8 MG Oral Tablet

1 INDICATIONS AND USAGE Ondansetron tablets are indicated for the prevention of nausea and vomiting associated with: highly emetogenic cancer chemotherapy, including cisplatin greater than or equal to 50 mg/m 2 . initial and repeat courses of moderately emetogenic cancer chemotherapy. radiotherapy in patients receiving either total body irradiation, single high-dose fraction to the abdomen, or daily fractions to the abdomen Ondansetron tablets are also indicated for the prevention of postoperative nausea and/or vomiting. Ondansetron tablets are 5-HT 3 receptor antagonist indicated for the prevention of: nausea and vomiting associated with highly emetogenic cancer chemotherapy, including cisplatin greater than or equal to 50 mg/m 2 (1) nausea and vomiting associated with initial and repeat courses of moderately emetogenic cancer chemotherapy (1) nausea and vomiting associated with radiotherapy in patients receiving either total body irradiation, single high-dose fraction to the abdomen, or daily fractions to the abdomen (1) postoperative nausea and/or vomiting (1)

Dr.Reddy's Laboratories Limited


3 years ago ROUND YELLOW R 154 Ondansetron 8 MG Oral Tablet

ROUND YELLOW R 154

3 years ago ROUND YELLOW R 154 Ondansetron 8 MG Oral Tablet

R 154 ROUND YELLOW

16 HOW SUPPLIED/STORAGE AND HANDLING Ondansetron Tablets Ondansetron Tablets Ondansetron tablets USP, 4 mg (

ONDANSETRON HYDROCHLORIDE USP, equivalent to 4 mg of ondansetron) are white, round, biconvex, film coated tablets debossed “R” on one side and “153” on other side and are supplied in bottles of 30, 100, 500, unit-dose packages of 100 (10 x 10) and unit-dose packages of 3 (1 x 3). Bottles of 30 NDC 55111-153-30 Bottles of 100 NDC 55111-153-01 Bottles of 500 NDC 55111-153-05 Unit Dose Packages of 100 (10 x 10) NDC 55111-153-78 Unit Dose Packages of 3 (1 x 3) NDC 55111-153-13 Ondansetron tablets USP, 8 mg (

ONDANSETRON HYDROCHLORIDE USP, equivalent to 8 mg of ondansetron) are yellow, round, biconvex, film coated tablets debossed “R” on one side and “154” on other side and are supplied in bottles of 30, 100, 500, unit-dose packages of 100 (10 x 10) and unit-dose packages of 3 (1 x 3). Bottles of 30 NDC 55111-154-30 Bottles of 100 NDC 55111-154-01 Bottles of 500 NDC 55111-154-05 Unit Dose Packages of 100 (10 x 10) NDC 55111-154-78 Unit Dose Packages of 3 (1 x 3) NDC 55111-154-13 Ondansetron tablets USP, 16 mg (

ONDANSETRON HYDROCHLORIDE USP, equivalent to 16 mg of ondansetron) are white, round, biconvex, film coated tablets debossed “R” on one side and “155” on other side and are supplied in bottles of 30, 500 and unit-dose packages of 100 (10 x 10). Bottles of 30 NDC 55111-155-30 Bottles of 500 NDC 55111-155-05 Unit-dose packages of 100 (10x10) NDC 55111-155-78 Ondansetron tablets USP, 24 mg (

ONDANSETRON HYDROCHLORIDE USP, equivalent to 24 mg of ondansetron) are pink, round, biconvex, film coated tablets debossed “R” on one side and “156” on other side and are supplied in bottles of 30, 500, unit-dose packages of 100 (10 x 10) and unit-dose packages of 1 (1 x 1). Bottles of 30 NDC 55111-156-30 Bottles of 500 NDC 55111-156-05 Unit Dose Packages of 100 (10 x 10) NDC 55111-156-78 Unit Dose Packages of 1 (1 x 1) NDC 55111-156-11 Store at 20°-25°C (68°-77°F) (See USP Controlled Room Temperature). Dispense in tight container as defined in the USP. Store blisters in cartons.

More pills like ROUND R 154

Related Pills












DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site